N-[2-(3-cyclopropyl-1,2,4-oxadiazol-5-yl)ethyl]-2-pyridin-3-ylacetamide

C14H16N4O2 — CID 77095090

IUPACN-[2-(3-cyclopropyl-1,2,4-oxadiazol-5-yl)ethyl]-2-pyridin-3-ylacetamide
SMILESO=C(Cc1cccnc1)NCCc1nc(C2CC2)no1
InChIInChI=1S/C14H16N4O2/c19-12(8-10-2-1-6-15-9-10)16-7-5-13-17-14(18-20-13)11-3-4-11/h1-2,6,9,11H,3-5,7-8H2,(H,16,19)
InChIKeyZWQGUGXZBVEKQU-UHFFFAOYSA-N
MW272.31 g/mol
LogP1.24
Rot. Bonds6

About N-[2-(3-cyclopropyl-1,2,4-oxadiazol-5-yl)ethyl]-2-pyridin-3-ylacetamide

N-[2-(3-cyclopropyl-1,2,4-oxadiazol-5-yl)ethyl]-2-pyridin-3-ylacetamide (PubChem CID 77095090) has the molecular formula C14H16N4O2 and a molecular weight of 272.31 g/mol. Its IUPAC name is N-[2-(3-cyclopropyl-1,2,4-oxadiazol-5-yl)ethyl]-2-pyridin-3-ylacetamide.

Molecular Properties

Compound NameN-[2-(3-cyclopropyl-1,2,4-oxadiazol-5-yl)ethyl]-2-pyridin-3-ylacetamide
PubChem CID77095090
Molecular FormulaC14H16N4O2
Molecular Weight272.31 g/mol
Exact Mass272.13
IUPAC NameN-[2-(3-cyclopropyl-1,2,4-oxadiazol-5-yl)ethyl]-2-pyridin-3-ylacetamide
SMILESO=C(Cc1cccnc1)NCCc1nc(C2CC2)no1
InChIInChI=1S/C14H16N4O2/c19-12(8-10-2-1-6-15-9-10)16-7-5-13-17-14(18-20-13)11-3-4-11/h1-2,6,9,11H,3-5,7-8H2,(H,16,19)
InChIKeyZWQGUGXZBVEKQU-UHFFFAOYSA-N
XLogP1.24
TPSA80.91 Ų
H-Bond Donors1
H-Bond Acceptors5
Rotatable Bonds6
Heavy Atoms20
Complexity—

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500272.31
LogP ≤ 51.24
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 105

Analyze N-[2-(3-cyclopropyl-1,2,4-oxadiazol-5-yl)ethyl]-2-pyridin-3-ylacetamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

3-(3-phenyl-1,2,4-oxadiazol-5-yl)-N-(2-pyridin-3-ylethyl)propanamide
CID 30768847
N-[2-(3-cyclopropyl-1,2,4-oxadiazol-5-yl)ethyl]-4-(1H-indol-3-yl)butanamide
CID 90649458
N-[2-(3-cyclopropyl-1,2,4-oxadiazol-5-yl)ethyl]-3-methylthiophene-2-carboxamide
CID 77092585
N-[2-(3-cyclopropyl-1,2,4-oxadiazol-5-yl)ethyl]-2-(4-methyl-1-oxophthalazin-2-yl)acetamide
CID 77080498
N-[2-(3-cyclopropyl-1,2,4-oxadiazol-5-yl)ethyl]-4-[(5-methyltetrazol-1-yl)methyl]benzamide
CID 119072785
N-(4-cyclopentylbutyl)-2-pyridin-3-ylacetamide
CID 71993774
N-(2-piperidin-4-yloxyethyl)-2-pyridin-3-ylacetamide
CID 63871778
benzyl 2-[3-(3-cyclopropyl-1,2,4-oxadiazol-5-yl)propanoylamino]acetate
CID 75372856
N-[2-(3-cyclopropyl-1,2,4-oxadiazol-5-yl)ethyl]-2-(oxolan-2-ylmethoxy)acetamide
CID 90649090
N-(2-methoxyethyl)-2-pyridin-3-ylacetamide
CID 110697049
2-(3-methyl-1,2-oxazol-5-yl)-N-[2-(3-pyridin-3-yl-1,2,4-oxadiazol-5-yl)ethyl]acetamide
CID 90647929
3-cyclopropyl-N-(2-pyridin-3-ylethyl)quinoxaline-2-carboxamide
CID 125420088

Frequently Asked Questions

What is the IUPAC name of N-[2-(3-cyclopropyl-1,2,4-oxadiazol-5-yl)ethyl]-2-pyridin-3-ylacetamide?
The IUPAC name of N-[2-(3-cyclopropyl-1,2,4-oxadiazol-5-yl)ethyl]-2-pyridin-3-ylacetamide (CID 77095090) is N-[2-(3-cyclopropyl-1,2,4-oxadiazol-5-yl)ethyl]-2-pyridin-3-ylacetamide.
What is the SMILES notation for N-[2-(3-cyclopropyl-1,2,4-oxadiazol-5-yl)ethyl]-2-pyridin-3-ylacetamide?
The canonical SMILES for N-[2-(3-cyclopropyl-1,2,4-oxadiazol-5-yl)ethyl]-2-pyridin-3-ylacetamide is O=C(Cc1cccnc1)NCCc1nc(C2CC2)no1.
What is the InChIKey of N-[2-(3-cyclopropyl-1,2,4-oxadiazol-5-yl)ethyl]-2-pyridin-3-ylacetamide?
The InChIKey is ZWQGUGXZBVEKQU-UHFFFAOYSA-N. The full InChI is InChI=1S/C14H16N4O2/c19-12(8-10-2-1-6-15-9-10)16-7-5-13-17-14(18-20-13)11-3-4-11/h1-2,6,9,11H,3-5,7-8H2,(H,16,19).
What are the key properties of N-[2-(3-cyclopropyl-1,2,4-oxadiazol-5-yl)ethyl]-2-pyridin-3-ylacetamide?
N-[2-(3-cyclopropyl-1,2,4-oxadiazol-5-yl)ethyl]-2-pyridin-3-ylacetamide has a molecular weight of 272.31 g/mol, XLogP of 1.24, 6 rotatable bonds, 1 hydrogen bond donors, and 5 hydrogen bond acceptors.
Where does this data come from?
All data for N-[2-(3-cyclopropyl-1,2,4-oxadiazol-5-yl)ethyl]-2-pyridin-3-ylacetamide is sourced from PubChem (CID 77095090), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).